Compile Data Set for Download or QSAR
Report error Found 20 Enz. Inhib. hit(s) with all data for entry = 11923
TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Shenzhen Chipscreen Biosciences Co.

US Patent
LigandPNGBDBM661248(4-((4-cyclopropyl-2-(N- methyl methanesulfonamido)...)
Affinity DataIC50: 0.0500nMAssay Description:Compound of the present invention formulated into different concentrations (series 3 times dilutions, started from 60 μM, 11 concentrations in t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Shenzhen Chipscreen Biosciences Co.

US Patent
LigandPNGBDBM661267(6-((2,6-dimethyl pyrimidin-4- yl)amino)-N-ethoxy-4...)
Affinity DataIC50: 0.0500nMAssay Description:Compound of the present invention formulated into different concentrations (series 3 times dilutions, started from 60 μM, 11 concentrations in t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Shenzhen Chipscreen Biosciences Co.

US Patent
LigandPNGBDBM661264(6-(((2,6-dimethyl pyrimidin- 4-yl)amino)-N-ethoxy-...)
Affinity DataIC50: 0.0500nMAssay Description:Compound of the present invention formulated into different concentrations (series 3 times dilutions, started from 60 μM, 11 concentrations in t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Shenzhen Chipscreen Biosciences Co.

US Patent
LigandPNGBDBM661261(4-((4-chloro-5-fluoro-2-(N- methyl methanesulfonam...)
Affinity DataIC50: 0.0600nMAssay Description:Compound of the present invention formulated into different concentrations (series 3 times dilutions, started from 60 μM, 11 concentrations in t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Shenzhen Chipscreen Biosciences Co.

US Patent
LigandPNGBDBM661263(4-((3-(1-cyclopropyl-1H- 1,2,4-triazol-3-yl)-5-flu...)
Affinity DataIC50: 0.0600nMAssay Description:Compound of the present invention formulated into different concentrations (series 3 times dilutions, started from 60 μM, 11 concentrations in t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Shenzhen Chipscreen Biosciences Co.

US Patent
LigandPNGBDBM661262(6-((2,6-dimethyl pyrimidin- 4-yl)amino)-N-ethoxy-4...)
Affinity DataIC50: 0.0600nMAssay Description:Compound of the present invention formulated into different concentrations (series 3 times dilutions, started from 60 μM, 11 concentrations in t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Shenzhen Chipscreen Biosciences Co.

US Patent
LigandPNGBDBM661948(US20240101548, Compound 201)
Affinity DataIC50: 0.0600nMAssay Description:Compound of the present invention formulated into different concentrations (series 3 times dilutions, started from 60 μM, 11 concentrations in t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Shenzhen Chipscreen Biosciences Co.

US Patent
LigandPNGBDBM661947(US20240101548, Compound 193)
Affinity DataIC50: 0.0600nMAssay Description:Compound of the present invention formulated into different concentrations (series 3 times dilutions, started from 60 μM, 11 concentrations in t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Shenzhen Chipscreen Biosciences Co.

US Patent
LigandPNGBDBM661257(6-(((2,6-dimethyl pyrimidin-4- yl)amino)-N-ethoxy-...)
Affinity DataIC50: 0.0700nMAssay Description:Compound of the present invention formulated into different concentrations (series 3 times dilutions, started from 60 μM, 11 concentrations in t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Shenzhen Chipscreen Biosciences Co.

US Patent
LigandPNGBDBM661946(US20240101548, Compound 115)
Affinity DataIC50: 0.0700nMAssay Description:Compound of the present invention formulated into different concentrations (series 3 times dilutions, started from 60 μM, 11 concentrations in t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Shenzhen Chipscreen Biosciences Co.

US Patent
LigandPNGBDBM661265(6-((2,6-dimethyl pyrimidin-4- yl)amino)-N-ethoxy-4...)
Affinity DataIC50: 0.0700nMAssay Description:Compound of the present invention formulated into different concentrations (series 3 times dilutions, started from 60 μM, 11 concentrations in t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Shenzhen Chipscreen Biosciences Co.

US Patent
LigandPNGBDBM661259(4-((4-cyclopropyl-5-fluoro-2- (N-methyl methanesul...)
Affinity DataIC50: 0.0800nMAssay Description:Compound of the present invention formulated into different concentrations (series 3 times dilutions, started from 60 μM, 11 concentrations in t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Shenzhen Chipscreen Biosciences Co.

US Patent
LigandPNGBDBM661260(4-((4-chloro-5-fluoro-2-(N- methyl methanesulfonam...)
Affinity DataIC50: 0.0800nMAssay Description:Compound of the present invention formulated into different concentrations (series 3 times dilutions, started from 60 μM, 11 concentrations in t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Shenzhen Chipscreen Biosciences Co.

US Patent
LigandPNGBDBM661258(4-((4-cyclopropyl-2-(N- methyl methanesulfonamido)...)
Affinity DataIC50: 0.0800nMAssay Description:Compound of the present invention formulated into different concentrations (series 3 times dilutions, started from 60 μM, 11 concentrations in t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Shenzhen Chipscreen Biosciences Co.

US Patent
LigandPNGBDBM661256(6-(((2,6-dimethyl pyrimidin-4- yl)amino)-N-ethoxy-...)
Affinity DataIC50: 0.0800nMAssay Description:Compound of the present invention formulated into different concentrations (series 3 times dilutions, started from 60 μM, 11 concentrations in t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Shenzhen Chipscreen Biosciences Co.

US Patent
LigandPNGBDBM661949(US20240101548, Compound 214)
Affinity DataIC50: 0.0900nMAssay Description:Compound of the present invention formulated into different concentrations (series 3 times dilutions, started from 60 μM, 11 concentrations in t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Shenzhen Chipscreen Biosciences Co.

US Patent
LigandPNGBDBM661249(4-((4-cyclopropyl-5-fluoro-2- (N-methyl methanesul...)
Affinity DataIC50: 0.0900nMAssay Description:Compound of the present invention formulated into different concentrations (series 3 times dilutions, started from 60 μM, 11 concentrations in t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Shenzhen Chipscreen Biosciences Co.

US Patent
LigandPNGBDBM661950(US20240101548, Compound 277)
Affinity DataIC50: 0.120nMAssay Description:Compound of the present invention formulated into different concentrations (series 3 times dilutions, started from 60 μM, 11 concentrations in t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Shenzhen Chipscreen Biosciences Co.

US Patent
LigandPNGBDBM661266(4-((3-(5-chloropyrimidin-2- yl)-2-methoxyphenyl)am...)
Affinity DataIC50: 0.130nMAssay Description:Compound of the present invention formulated into different concentrations (series 3 times dilutions, started from 60 μM, 11 concentrations in t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Shenzhen Chipscreen Biosciences Co.

US Patent
LigandPNGBDBM500288(US11021475, Example 67 | US11021475, Example 52 | ...)
Affinity DataIC50: 0.140nMAssay Description:Compound of the present invention formulated into different concentrations (series 3 times dilutions, started from 60 μM, 11 concentrations in t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
Go to US Patent